Longevity Health Holdings, Inc. Warrant
XAGEW
XAGEW was delisted on the 11th of September, 2025.
9 hedge funds and large institutions have $1.23M invested in Longevity Health Holdings, Inc. Warrant in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Balyasny Asset Management
Chicago,
Illinois
|
+$447K |
| 2 |
AC
Antara Capital
New York
|
+$236K |
| 3 |
SC
Sculptor Capital
New York
|
+$222K |
| 4 |
TAM
TFG Asset Management
Grand Cayman,
Cayman Islands
|
+$90.3K |
| 5 |
EAM
Exos Asset Management
New York
|
+$68.7K |
Top Sellers
XAGEW Hedge Fund Activity: Q3 2021 in Review
9 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Longevity Health Holdings, Inc. Warrant (XAGEW) for Q3 2021, worth a combined $1.23M.
Buyers outnumbered sellers: 9 funds opened new XAGEW positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Balyasny Asset Management, opening a new position worth an estimated $447K.
- 9 institutional investors held Longevity Health Holdings, Inc. Warrant (XAGEW) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $1.23M of Longevity Health Holdings, Inc. Warrant stock for Q3 2021.
- 9 funds opened new Longevity Health Holdings, Inc. Warrant positions in Q3 2021 and 0 closed out, a net change of +9 holders.
- The largest Longevity Health Holdings, Inc. Warrant buyer in Q3 2021 was Balyasny Asset Management, an estimated $447K added.
Based on aggregated 13F filings for Q3 2021.